Anders HJ - Search Results

1

Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial.

Anders HJ, Furie R, Malvar A, Zhao MH, Hiromura K, Weinmann-Menke J, Green Y, Jones-Leone A, Negrini D, Levy RA, Lightstone L, Tanaka Y, Rovin BH. Anders HJ, et al. Nephrol Dial Transplant. 2023 Nov 30;38(12):2733-2742. doi: 10.1093/ndt/gfad167. Nephrol Dial Transplant. 2023. PMID: 37463054 Free PMC article. Clinical Trial.

2

Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis.

Weidenbusch M, Römmele C, Schröttle A, Anders HJ. Weidenbusch M, et al. Among authors: anders hj. Nephrol Dial Transplant. 2013 Jan;28(1):106-11. doi: 10.1093/ndt/gfs285. Epub 2012 Jul 3. Nephrol Dial Transplant. 2013. PMID: 22764193 Review.

3

Nrf2 signalling promotes ex vivo tubular epithelial cell survival and regeneration via murine double minute (MDM)-2.

Hagemann JH, Thomasova D, Mulay SR, Anders HJ. Hagemann JH, et al. Among authors: anders hj. Nephrol Dial Transplant. 2013 Aug;28(8):2028-37. doi: 10.1093/ndt/gft037. Epub 2013 Mar 8. Nephrol Dial Transplant. 2013. PMID: 23476038

4

Unmet medical needs in lupus nephritis: solutions through evidence-based, personalized medicine.

Anders HJ, Weidenbusch M, Rovin B. Anders HJ, et al. Clin Kidney J. 2015 Oct;8(5):492-502. doi: 10.1093/ckj/sfv072. Epub 2015 Aug 27. Clin Kidney J. 2015. PMID: 26413272 Free PMC article.

5

Hurdles to the introduction of new therapies for immune-mediated kidney diseases.

Anders HJ, Jayne DR, Rovin BH. Anders HJ, et al. Nat Rev Nephrol. 2016 Apr;12(4):205-16. doi: 10.1038/nrneph.2015.206. Epub 2016 Jan 25. Nat Rev Nephrol. 2016. PMID: 26804020 Review.

6

A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis.

Anders HJ, Rovin B. Anders HJ, et al. Kidney Int. 2016 Sep;90(3):493-501. doi: 10.1016/j.kint.2016.05.017. Epub 2016 Jul 1. Kidney Int. 2016. PMID: 27378475 Free article. Review.

7

Introduction: Translational Immunology in Kidney Disease.

Anders HJ, Jayne D, Rovin B. Anders HJ, et al. Semin Nephrol. 2017 Sep;37(5):417. doi: 10.1016/j.semnephrol.2017.05.015. Semin Nephrol. 2017. PMID: 28863789 No abstract available.

8

Dipeptidyl peptidase-4 inhibitor teneligliptin accelerates recovery from cisplatin-induced acute kidney injury by attenuating inflammation and promoting tubular regeneration.

Iwakura T, Zhao Z, Marschner JA, Devarapu SK, Yasuda H, Anders HJ. Iwakura T, et al. Among authors: anders hj. Nephrol Dial Transplant. 2019 Oct 1;34(10):1669-1680. doi: 10.1093/ndt/gfy397. Nephrol Dial Transplant. 2019. PMID: 30624740

9

2018 update in basic kidney research: fibrosis, inflammation, glomerular filtration and kidney disease progression.

Anders HJ. Anders HJ. Nephrol Dial Transplant. 2019 May 1;34(5):719-723. doi: 10.1093/ndt/gfz006. Nephrol Dial Transplant. 2019. PMID: 30778545 No abstract available.

10

2019 Update in basic kidney research: microbiota in chronic kidney disease, controlling autoimmunity, kidney inflammation and modelling the glomerular filtration barrier.

Anders HJ. Anders HJ. Nephrol Dial Transplant. 2020 Jan 1;35(1):4-9. doi: 10.1093/ndt/gfz219. Nephrol Dial Transplant. 2020. PMID: 31943087 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

461 results

Search Page